Supply Chain

Improving data-driven decision making is the area supply chain leaders deemed most critical to the future of supply chain in healthcare, according to a survey of the Best 50 provider organizations conducted by the Global Healthcare Exchange.

President Donald Trump reaffirmed his pledge to lower prescription drug prices at a March 19 speech in Manchester, N.H., and said his administration would introduce new steps to address this issue next month, according to Reuters.

Seventy U.S. hospitals expressed interest in joining a nonprofit generic drug company venture formed by four health systems across the country and the U.S. Department of Veterans Affairs, according to Politico.

The FDA released an inspection report into Cleveland-based Philips Medical Systems, part of Amsterdam-based Royal Philips, stating the company mishandled thousands of complaints.

The FDA on March 16 approved CSL Behring's drug Hizentra to treat chronic inflammatory demyelinating polyneuropathy.

Bayer recalled some Alka-Seltzer Plus products after discovering ingredients listed on the package's front sticker may differ from the product's actual ingredients.

Consumers in Massachusetts may now sue brand-name drugmakers for injuries caused by generic versions of their own drugs, reports Reuters.

Arkansas lawmakers on March 14 approved what is likely the first bill in the U.S. to permit state-level regulation of pharmacy benefit managers, according to Arkansas Times.

Everyone is on a budget these days, including hospitals and health systems. While operating within increasingly tighter margins, hospitals and health systems must ensure they are providing quality care.

A group of bipartisan senators introduced two pieces of prescription drug legislation, including a ban on "gag clauses" that can lead to consumers paying higher prices at the pharmacy.